New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Ozempic, also known by its generic name semaglutide, has recently become a hot topic in conversations about weight management. Originally developed to help people with type 2 diabetes ... dosage.

Because of the difference in dosage, Ozempic is FDA-approved only to treat type 2 diabetes, while Wegovy is FDA-approved for weight loss. Likewise, Mounjaro and Zepbound are also identical ...

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

Michael Sabellico, 1 60-year-old took Ozempic in March 2024 to manage his Type 2 diabetes and lose weight ... lost weight successfully. But after eight weeks on a 1.5 mg dose, he woke up one ...

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...

Altimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss ...

(Image Credits: Pexel) A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide ... group experienced an average weight loss of 21.4% and a 0.67 percentage point ...